This is the authors' abstract. We don't add key points for this paper.
Multi-enzymatic syntheses of L-[β-11C]tryptophan and 5-hydroxy-L-[β-11C]tryptophan from racemic [3-11C]alanine are reported. 11C-Labelled alanine was prepared by an alkylation of a glycine derivative, N(diphenylmethylene)glycine t-butyl ester, with [11C]methyl iodide obtained from [11C]carbon dioxide, and subsequent hydrolysis. The enzymatic syntheses were carried out in a one-pot reaction using D-amino acid oxidase/catalase, glutamic-pyruvic transaminase, and tryptophanase. The total synthesis time was 50 to 55 min, including h.p.l.c. purification, counted from the start of [11C]methyl iodide synthesis. The yields were ca. 25%, decay corrected, of purified sterilized enantiomerically pure L-[β-11C]tryptophan and 5-hydroxy-L-[β-11C]tryptophan with radiochemical purifies of >98%. The specific activities were in the order of 2.5 GBq/µmol. In a typical run starting with 4.4 GBq [11C]carbon dioxide, 220 MBq of β-11C-labelled L-tryptophan or 5-hydroxy-L-tryptophan was obtained ready for use in human studies.
No takes yet. Share an insight, caveat, or question.
Bjurling et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: